← FDA DRUG APPROVALS

FDA ANDA · ANDA075677

ACYCLOVIR

Sponsor: APOTEX

APPLICATION
ANDA075677
TYPE
ANDA
ORIGINAL APPROVAL
2005-09-28
LATEST ACTION
2026-01-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

ACYCLOVIRPrescription
ACYCLOVIR 200MG · CAPSULE · ORAL

Approval history

2026-01-22Labeling · Supplement 12 · standardAP
2006-03-06Labeling · Supplement 1AP
2005-09-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →